342P - QOL analysis of a phase II randomized controlled clinical trial comparing efficacy of cabazitaxel versus docetaxel as second line or above therapy in recurrent head and neck cancer
| Autor: | Chanana, R., Noronha, V., Joshi, A., Patil, V., Dhumal, S., Bhattacharya, A., Chandrasekharan, A., Pande, N., Talreja, V.T., Turkar, S., Shrirangwar, S., Prabhash, K. |
|---|---|
| Zdroj: | In Annals of Oncology November 2017 28 Supplement 10:x102-x102 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|